A benzimidazole broad-spectrum anthelmintic structurally related to mebendazole that is effective against many diseases. (From Martindale, The Extra Pharmacopoeia, 30th ed, p38)
For the treatment of parenchymal neurocysticercosis due to active lesions caused by larval forms of the pork tapeworm, Taenia solium and for the treatment of cystic hydatid disease of the liver, lung, and peritoneum, caused by the larval form of the dog tapeworm, Echinococcus granulosus.
Committee on Human Research Publications and Ethics, Kumasi, Ashanti, Ghana
George Washington University, Washington, District of Columbia, United States
Dow University of Health Sciences, Karachi, Sindh, Pakistan
1 Moriba Street, Pujehun, Pujehun District, Sierra Leone
The Carter Center Ethiopia, Addis Ababa, Ethiopia
Institut de Recherche pour le Développement, Comé, Benin
London School of Hygiene and Tropical Medicine, Mangochi, Malawi
Christian Medical College, Vellore, India
Cote d'Ivoire, Abidjan, Côte D'Ivoire
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.